SMC2 and posterior cortical atrophy: CAPE pre-treatment (20, 40 and 80 μM) for 24 h dose-dependently suppressed the migration and invasion of PC-3 and DU-145 PCa cells as determined by transwell assay (Figure 1A, 1B) and wound healing assay (Figure 1C, 1D).